ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
OpenAI Nears Astra AI Model Launch With Safety Focus 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO 
Milei Threatens Falkland Oil Firms With Sanctions 
Anthropic IPO Marketing Expected to Start in Mid-October 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
Add as a preferred source on Google
MOUNTAIN VIEW, Calif., Feb. 27, 2018 -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company plans to participate in the upcoming 30th Annual Roth Conference in Orange County, CA.
IRIDEX’s management is scheduled to present on Tuesday, March 13, 2018 at 11:00am PT. Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.
About IRIDEX
IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.
Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
[email protected]
